Physician profile
Lee Sonin
NPI 1376571497
$7,398.29
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,335 · 2020: $1,250 · 2021: $2,026 · 2022: $1,742 · 2023: $44.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,310.90 | 2019-2023 | Fasenra |
| Glaxosmithkline, LLC. | $1,111.69 | 2019-2022 | |
| Csl Behring | $1,094.83 | 2019-2023 | Haegarda, Kcentra |
| Regeneron Healthcare Solutions, INC. | $682.69 | 2019-2022 | |
| Optinose US, INC. | $592.51 | 2019-2022 | |
| Biocryst US Sales Co., LLC | $407.92 | 2021-2022 | |
| Covis Pharma Gmbh | $344.99 | 2019-2022 | |
| Genentech USA, INC. | $264.50 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $229.36 | 2020-2022 | |
| Shire North American Group INC | $184.21 | 2019 | |
| Pharming Healthcare, INC. | $172.02 | 2019-2022 | |
| Pfizer INC. | $149.57 | 2019-2021 | |
| Amgen INC. | $130.25 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $114.23 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $78.43 | 2019-2020 | |
| Genzyme Corporation | $60.50 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $54.74 | 2021-2022 | |
| Biocryst Pharmaceuticals, INC. | $44.58 | 2020 | |
| Aimmune Therapeutics, INC. | $34.20 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.10 | 2021-2022 | |
| Alk-Abello, INC | $26.75 | 2020-2021 | |
| Uswm, LLC | $25.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Sonin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.